SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories submits press release

19 Apr 2021 Evaluate

Caplin Point Laboratories has informed that it enclosed a Press Release regarding 'Caplin Steriles Gets USFDA Approval for Milrinone lactate Injection', for dissemination.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Labs. Share Price

2559.40 -64.75 (-2.47%)
01-Jul-2026 12:49 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1873.85
Dr. Reddys Labs. 1342.75
Cipla 1450.20
Zydus Lifesciences 1110.00
Lupin 2399.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: